Copyright
©The Author(s) 2019.
World J Stem Cells. Feb 26, 2019; 11(2): 55-72
Published online Feb 26, 2019. doi: 10.4252/wjsc.v11.i2.55
Published online Feb 26, 2019. doi: 10.4252/wjsc.v11.i2.55
Table 1 Tissue sources of mesenchymal stem cells
| Tissue sources | MSCs | Ref. |
| Bone marrow | BM-MSCs | [115] |
| Adipose | Ad-MSCs | [116] |
| Placenta | Pl-MSCs | [117] |
| Skin | S-MSCs | [118] |
| Umbilical cord blood | UCB-MSCs | [119] |
| Umbilical cord perivascular cells | UCPVC-MSCs | [120] |
| Umbilical cord Wharton’s jelly | WJ-MSCs | [121] |
| Amniotic fluid | AF-MSCs | [122] |
| Synovial membrane | SM-MSCs | [123] |
| Breast milk | M-MSCs | [124] |
| Alveolar epithelium (lung) | AE-MSCs | [125] |
| Myocardium (heart) | Myo-MSCs | [126] |
| Menstrual blood | Men-MSCs | [127] |
| Endometrium | En-MSCs | [128] |
Table 2 Autoimmune diseases, autism spectrum disorders, and mesenchymal stem cells
| Autoimmune diseases | ASD | MSCs |
| Autoimmune thyroiditis | + | Pre-clinical experiment |
| Rheumatoid arthritis | + | Pre-clinical experiment; Clinical trials on-going |
| GVHD | - | Pre-clinical experiment; Clinical trials |
| MS | - | Pre-clinical experiment; Clinical trials on-going |
| Type 1 diabetes | + | Pre-clinical experiment; Clinical trials on-going |
- Citation: Liu Q, Chen MX, Sun L, Wallis CU, Zhou JS, Ao LJ, Li Q, Sham PC. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders. World J Stem Cells 2019; 11(2): 55-72
- URL: https://www.wjgnet.com/1948-0210/full/v11/i2/55.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i2.55
